5-Cog 2.0: A Pragmatic Clinical Trial (NCT05515224)
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
Cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. This problem is more prevalent in health disparities populations. The investigators developed the 5-Cog brief cognitive assessment that is simple to use, standardized, takes \<5 minutes, does not require informants, and accounts for major technical, cultural, and logistical barriers of current assessments. The investigators propose a hybrid Type 1 effectiveness-implementation design in real-world settings to adapt and test the effectiveness of the 5-Cog paradigm to increase detection of cognitive impairment care in older adults presenting with cognitive concerns. The study aim is to evaluate, using a pragmatic cluster-randomized trial design, the effectiveness of the 5-Cog paradigm to increase 'incident cognitive impairment' detection (new MCI and dementia diagnoses) relative to enhanced usual care in 6,600 older patients presenting with cognitive concerns in 22 primary care clinics in Bronx and Indiana. As diagnosis without action will not improve patient care, 'improved dementia care' will be examined as a secondary outcome. Results will also be examined in NIH designated health disparity populations including underserved minority and socio-economically challenged populations.
Who can join: Review the eligibility criteria below.
Location: Indiana University — Bloomington, Indiana
Age range: 65 Years
🧪 Interventions in This Study
- 5-Cog Paradigm (5-Cog battery coupled with clinical decision tool) (OTHER)
- Enhanced usual care (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Indiana University — Bloomington, Indiana
- Albert Einstein College of Medicine — The Bronx, New York
📞 Contact the Study Coordinator
Phone: (718) 430-3835
Email: emmeline.ayers@einsteinmed.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Dementia
- A Virtual Reality at Home Intervention for People Living With Dementia — Toronto, Ontario
- Caregiver Bootcamp — Atlanta, Georgia
- A Spanish-language Caregiver-Enabled Care Program — Carlsbad, California
- The Sunnybrook Dementia Study — Toronto, Ontario
- Palliative Care for Patients With Dementia — New York, New York
- Cognitive Health Awareness Program in Surgical Patients — Toronto, Ontario
Explore by condition: All Dementia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.